Home > News > Headline News > Archive

Click on title to read the full article.

Technique Filters Cancer Where Chemo Can't Reach

July 31, 2013

By Health News Digest

A cancer therapy that removes malignant cells from a patient's cerebrospinal fluid may soon be available to prevent metastases and decrease complications of cancers involving the brain, according to Penn State medical researchers.

Scientists Seek to Rein In Diagnoses of Cancer

July 30, 2013

By Tara Parker-Pope, New York Times

A group of experts advising the nation’s premier cancer research institution has recommended changing the definition of cancer and eliminating the word from some common diagnoses as part of sweeping changes in the nation’s approach to cancer detection and treatment.

The recommendations, from a working group of the National Cancer Institute, were published on Monday in The Journal of the American Medical Association. They say, for instance, that some premalignant conditions, like one that affects the breast called ductal carcinoma in situ, which many doctors agree is not cancer, should be renamed to exclude the word carcinoma so that patients are less frightened and less likely to seek what may be unneeded and potentially harmful treatments that can include the surgical removal of the breast.

Technique Filters Cancer Where Chemo Can't Reach

July 30, 2013

By Health News Digest

NBCC and BioMarin Pharmaceutical Inc. Collaborate on BMN 673

July 29, 2013

By NBCC press release

The National Breast Cancer Coalition (NBCC) and BioMarin Pharmaceutical Inc. (Nasdaq:  BMRN) have announced a collaboration to develop BioMarin’s PARP inhibitor for the treatment of hereditary breast cancer with BRCA mutations. NBCC will have input and representation in study design, implementation and execution. In addition, NBCC will support trial enrollment initiatives in the United States and around the world.  BioMarin is planning to initiate a Phase 3 trial for BMN 673 in deleterious gBRCA mutation metastatic breast cancer in the fall.

Gene that May Stop the Spread of Breast Cancer is Identified

July 24, 2013

By Newswire Rutgers Robert Wood Johnson Medical School

A new study by Kiran Chada, PhD, professor of biochemistry and molecular biology at Robert Wood Johnson Medical School, part of Rutgers, The State University of New Jersey, shows that metastasis in breast cancer and the risk of death are reduced when the function of the gene HGMA2, is limited.


July 18, 2013

By MBCN Press Release

NEW YORK-JULY 18, 2013-Hundreds of metastatic breast cancer patients will convene in Houston for the Metastatic Breast Cancer Network's (MBCN's) 7th Annual National Conference presented in conjunction with MD Anderson Cancer Center on September 20-22, 2013. "We're really excited to offer expanded breakout sessions and networking opportunities," says conference chair and MBCN board member Deb Tincher. "This year's theme is ‘New Directions in Metastatic Breast Cancer.' Our expert speakers will address cutting-edge developments in treating metastatic breast cancer as well as everyday issues confronting people living with the disease."


July 17, 2013

By Anahad O'Connor, NY Times

A new radiation therapy can extend the lives of men with the most advanced form of prostate cancer, a large new study has found.
The drug's mechanism is not specific to prostate cancers. In clinical trials it has also shown promise in treating bone metastases resulting from breast cancer.